Role of medical reaction in management of inappropriate ventricular arrhythmia diagnosis: the inappropriate Therapy and HOme monitoRiNg (THORN) registry. Issue 4 (2nd January 2019)

• Record Type: Journal Article
• Authors: Perrin, Tilman; Boveda, Serge; Defaye, Pascal; Rosier, Arnaud; Sadoul, Nicolas; Bordachar, Pierre; Klug, Didier; Ritter, Philippe; Belhameche, Mohamed; Babuty, Dominique; Mansourati, Jacques; Lazarus, Arnaud; Deharo, Jean-Claude
• Is Part Of: Europace. Volume 21:Issue 4(2019)
• Page Start: 607
• Page End: 615
• Publication Date: 2019-01-02
• Subjects: Implantable cardioverter-defibrillator -- Inappropriate implantable cardioverter-defibrillator shock -- Inappropriate implantable cardioverter-defibrillator therapy -- Inappropriate ventricular arrhythmia diagnosis -- Medical reaction time -- Remote monitoring; Arrhythmia -- Treatment -- Periodicals; Cardiac pacing -- Periodicals; Catheter ablation -- Periodicals; Heart -- Physiology -- Periodicals; Electrophysiology -- Periodicals; 617.4120645
• DOI: 10.1093/europace/euy284
• Languages: English
• ISSNs: 1099-5129

Abstract

Abstract: Aims: Implantable cardioverter-defibrillators (ICDs) reduce sudden cardiac death in selected patients but inappropriate ICD shocks have been associated with increased mortality. The THORN registry aims to describe the rate of inappropriate ventricular arrhythmia diagnoses and therapies in patients followed by remote monitoring, as well as the following delay to next patient contact (DNPC). Methods and results: One thousand eight hundred and eighty-two patients issued from a large remote monitoring database first implanted with an ICD for primary or secondary prevention in 110 French hospitals from 2007 to 2014 constitute the THORN population. Among them, 504 patients were additionally followed prospectively for evaluation of the DNPC. Eight hundred and ninety-five out of 1551 (58%) patients had ischaemic heart disease and 358/771 (46%) were implanted for secondary prevention. During 13.7 ± 3.4 months of follow-up, the prevalence of first inappropriate diagnosis in a ventricular arrhythmia zone with enabled therapy was 162/1882 (9%). Among those patients, 122/162 (75%) suffered at least one inappropriate therapy and 58/162 (36%) at least one inappropriate shock. Eighty-three out of 162 (51%) of first inappropriate diagnosis occurred during the first 4 months following implantation. The median DNPC was 8 days (interquartile range 1–26). At least one other day with recording of an inappropriate diagnosis of the same cause occurred in 13/43 (30%) of available DNPC periods, with an inappropriate therapy in 7/13 (54%). Conclusion: Inappropriate diagnoses occurred in 9% of patients implanted with an ICD during the first 14 months. The DNPC after inadequate ventricular arrhythmia diagnoses remains long in daily practice and should be optimized. ClinicalTrials.gov Identifier: NCT01594112.